Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1985 Feb;44(2):89–92. doi: 10.1136/ard.44.2.89

Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.

M A French, G Harrison, C A Penning, J Cunningham, P Hughes, N R Rowell
PMCID: PMC1001579  PMID: 3919660

Abstract

In a comparative study of antinuclear antibodies (ANA) and immune complexes in the serum of 43 patients with systemic sclerosis (SS) ANA were detected by indirect immunofluorescence on Hep 2 cells and/or double immunodiffusion in 90% of patients, while immune complex assays were positive in 32% of patients. The immune complex assays were positive only in sera containing antibodies to Scl 70, n-RNP, Ro, and La. The presence of immune complexes in SS sera is therefore related to ANA specificity. This might explain the variable findings of several previous studies of immune complexes in SS.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander E. L., Arnett F. C., Provost T. T., Stevens M. B. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983 Feb;98(2):155–159. doi: 10.7326/0003-4819-98-2-155. [DOI] [PubMed] [Google Scholar]
  2. Bernstein R. M., Steigerwald J. C., Tan E. M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol. 1982 Apr;48(1):43–51. [PMC free article] [PubMed] [Google Scholar]
  3. Catoggio L. J., Bernstein R. M., Black C. M., Hughes G. R., Maddison P. J. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis. 1983 Feb;42(1):23–27. doi: 10.1136/ard.42.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clark G., Reichlin M., Tomasi T. B., Jr Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol. 1969 Jan;102(1):117–122. [PubMed] [Google Scholar]
  5. Cunningham P. H., Andrews B. S., Davis J. S., 4th Immune complexes in progressive systemic sclerosis and mixed connective tissue disease. J Rheumatol. 1980 May-Jun;7(3):301–308. [PubMed] [Google Scholar]
  6. Fritzler M. J., Kinsella T. D. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med. 1980 Oct;69(4):520–526. doi: 10.1016/0002-9343(80)90462-3. [DOI] [PubMed] [Google Scholar]
  7. Horsfall A. C., Venables P. J., Mumford P. A., Maini R. N. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes. Clin Exp Immunol. 1981 May;44(2):405–415. [PMC free article] [PubMed] [Google Scholar]
  8. Hughes P., Cunningham J., Day M., Fitzgerald J. C., French M. A., Wright J. K., Rowell N. R. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol. 1983 Mar;10(3):133–138. [PubMed] [Google Scholar]
  9. Hughes P., Holt S., Rowell N. R., Allonby I. D., Janis K., Dodd J. K. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis. Clin Exp Immunol. 1977 May;28(2):233–240. [PMC free article] [PubMed] [Google Scholar]
  10. LeRoy E. C. The heart in systemic sclerosis. N Engl J Med. 1984 Jan 19;310(3):188–190. doi: 10.1056/NEJM198401193100309. [DOI] [PubMed] [Google Scholar]
  11. O'Loughlin S., Tappeiner G., Jordon R. E. Circulating immune complexes in systemic scleroderma and generalized morphea. Dermatologica. 1980;160(1):25–30. doi: 10.1159/000250463. [DOI] [PubMed] [Google Scholar]
  12. Penning C. A., Cunningham J., French M. A., Harrison G., Rowell N. R., Hughes P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol. 1984 Sep;57(3):548–556. [PMC free article] [PubMed] [Google Scholar]
  13. Pisko E., Gallup K., Turner R., Parker M., Nomeir A. M., Box J., Davis J., Box P., Rothberger H. Cardiopulmonary manifestations of progressive systemic sclerosis: associations with circulating immune complexes and fluorescent antinuclear antibodies. Arthritis Rheum. 1979 May;22(5):518–523. doi: 10.1002/art.1780220512. [DOI] [PubMed] [Google Scholar]
  14. Reichlin M. Clinical and immunological significance of antibodies to Ro and La in systemic lupus erythematosus. Arthritis Rheum. 1982 Jul;25(7):767–771. doi: 10.1002/art.1780250710. [DOI] [PubMed] [Google Scholar]
  15. Siminovitch K., Klein M., Pruzanski W., Wilkinson S., Lee P., Yoon S. J., Keystone E. Circulating immune complexes in patients with progressive systemic sclerosis. Arthritis Rheum. 1982 Oct;25(10):1174–1179. doi: 10.1002/art.1780251005. [DOI] [PubMed] [Google Scholar]
  16. Sølling J., Sølling K., Jacobsen K. U. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis. Acta Derm Venereol. 1979;59(5):421–426. [PubMed] [Google Scholar]
  17. Venables P. J., Erhardt C. C., Maini R. N. Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes. Clin Exp Immunol. 1980 Jan;39(1):146–153. [PMC free article] [PubMed] [Google Scholar]
  18. Venables P. J., Roffe L. M., Erhardt C. C., Maini R. N., Edwards J. M., Porter A. D. Titers of antibodies to RANA in rheumatoid arthritis and normal sera. Relationship to Epstein-Barr virus infection. Arthritis Rheum. 1981 Dec;24(12):1459–1468. doi: 10.1002/art.1780241201. [DOI] [PubMed] [Google Scholar]
  19. Venables P. J., Yi T., Woodrow D. F., Moss J., Maini R. N. Relationship of precipitating antibodies to soluble cellular antigens and histologically defined renal lesions in systemic lupus erythematosus. Ann Rheum Dis. 1983 Feb;42(1):17–22. doi: 10.1136/ard.42.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES